Cargando…
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis
INTRODUCTION: Sugammadex is used for the reversal of neuromuscular blockade caused by rocuronium bromide and vecuronium bromide. As part of the post licensing phase of drug development, adverse events related to the use of sugammadex are still being uncovered and being reported. The potential associ...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700844/ https://www.ncbi.nlm.nih.gov/pubmed/31452867 http://dx.doi.org/10.1177/2042098619869077 |